An investigation follows counterfeit weight loss injections from a single warehouse back to the international network that supplies them.
Recap by typeshit. Full story at The Times.
The non-binding vote went against the FDA's own scientists, who opposed every peptide. Six of the eight new panel members run clinics that offer peptides.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
A TriNetX analysis of type 2 diabetes patients saw no excess breathing complications, though a hypocalcemia signal versus SGLT2 drugs needs a closer look.
A short fitness clip pushing back on stigma around GLP-1 drugs. Light on detail beyond the message itself.
Loading…